{{Rsnum
|rsid=1876206
|Gene=FBN1
|Chromosome=15
|position=48608389
|Orientation=plus
|GMAF=0.1203
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=FBN1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 74.8 | 22.5 | 2.7
| HCB | 84.4 | 15.6 | 0.0
| JPT | 80.0 | 17.8 | 2.2
| YRI | 90.5 | 9.5 | 0.0
| ASW | 80.4 | 17.9 | 1.8
| CHB | 84.4 | 15.6 | 0.0
| CHD | 75.5 | 22.6 | 1.9
| GIH | 74.0 | 25.0 | 1.0
| LWK | 80.0 | 18.1 | 1.9
| MEX | 74.5 | 23.6 | 1.8
| MKK | 70.5 | 24.4 | 5.1
| TSI | 85.0 | 13.0 | 2.0
| HapMapRevision=28
}}
{{PMID Auto GWAS
|PMID=17903305
|Trait=Breast cancer
|Title=A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study
|RiskAllele=
|Pval=0.0000060000000000000002
|OR=NR
|ORtxt=NR
|OA=1
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1876206
|overall_frequency_n=12
|overall_frequency_d=128
|overall_frequency=0.09375
|n_genomes=10
|n_genomes_annotated=0
|n_haplomes=11
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}